CY 1787

Drug Profile

CY 1787

Alternative Names: CY-1787; CY-1788

Latest Information Update: 26 Apr 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Epimmune
  • Developer Epimmune; Pharmacia Corporation; Sumitomo Pharmaceuticals
  • Class Monoclonal antibodies
  • Mechanism of Action E-selectin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Allergic rhinitis; Septic shock; Systemic inflammatory response syndrome

Most Recent Events

  • 26 Apr 1999 Discontinued-I for Allergic rhinitis in United Kingdom (Unknown route)
  • 26 Apr 1999 Discontinued-I for Septic shock in Belgium (Unknown route)
  • 26 Apr 1999 Discontinued-Preclinical for Septic shock in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top